Search Within

Sacha Gnjatic

  1. "Solid Tumor Oncology Division"
  2. "Lloyd Old"
Formats
  1. Journal Article (10)
  2. Meeting Abstract (8)
Groups
  1. Department of Medicine (18)
  2. Solid Tumor Oncology Division (18)
  3. Sloan Kettering Institute Postdocs (10)
  4. GSK Faculty (7)
  5. Genitourinary Oncology Service (7)
  6. Melanoma and Immunotherapeutics Service (6)

More Groups

People
  1. Lloyd Old (18)
  2. Achim Jungbluth (13)
  3. Gerd Ritter (10)
  4. Erika Ritter (9)
  5. James Allison (7)
  6. Humilidad Gallardo (6)

More People

Years
  1. 2013 (2)
  2. 2012 (1)
  3. 2011 (1)
  4. 2010 (3)
  5. 2008 (5)
  6. 2007 (1)

More Years

Publications
  1. Journal of Clinical Oncology (4)
  2. Journal of Immunotherapy (4)
  3. Clinical Cancer Research (3)
  4. Proceedings of the National Academy of Sciences of the United States of America (3)
  5. Cancer Immunity (2)
  6. Pigment Cell & Melanoma Research (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (4)
  2. Lippincott Williams & Wilkins (4)
  3. American Association for Cancer Research (3)
  4. National Academy of Sciences (3)
  5. Academy of Cancer Immunology (2)
  6. Hindawi Publishing Corporation (1)

More Publishers

Results (18)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prostate cancer progression correlates with increased humoral immune response to a human endogenous retrovirus GAG protein
    Journal Article

    Reis, B. S.; Jungbluth, A. A.; Frosina, D.; Holz, M.; Ritter, E.; Nakayama, E.; Ishida, T.; Obata, Y.; Carver, B.; Scher, H.; more...
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save
  • A pilot study of anti-CTLA4 antibody ipilimumab in patients with synovial sarcoma
    Journal Article

    Maki, R. G.; Jungbluth, A. A.; Gnjatic, S.; Schwartz, G. K.; D'Adamo, D. R.; Keohan, M. L.; Wagner, M. J.; Scheu, K.; Chiu, R.; Ritter, E.; more...
    Sarcoma (2013)

    Fulltext@MSK | Save
  • Phase I trial of overlapping long peptides from a tumor self-antigen and poly-ICLC shows rapid induction of integrated immune response in ovarian cancer patients
    Journal Article

    Sabbatini, P.; Tsuji, T.; Ferran, L.; Ritter, E.; Sedrak, C.; Tuballes, K.; Jungbluth, A. A.; Ritter, G.; Aghajanian, C.; Bell-Mcguinn, K.; more...
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
    Journal Article

    Yuan, J.; Adamow, M.; Ginsberg, B. A.; Rasalan, T. S.; Ritter, E.; Gallardo, H. F.; Xu, Y.; Pogoriler, E.; Terzulli, S. L.; Kuk, D.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2011)

    Fulltext@MSK | Save
  • A phase I study of NY-ESO-1 overlapping peptides with or without incomplete Freund's adjuvant and poly-ICLCL vaccination of ovarian cancer patients in second or third clinical remission
    Meeting Abstract

    Diefenbach, C. S. M.; Sabbatini, P.; Hensley, M. L.; Konner, J. A.; Tew, W. P.; Ritter, G.; Jungbluth, A.; Pan, L. S.; Old, L. J.; Gnjatic, S.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • NY-ESO-1-specific CD8 T cell response in NY-ESO-1 seropositive metastatic melanoma patients treated with ipilimumab correlates with clinical benefit
    Meeting Abstract

    Yuan, J. D.; Gnjatic, S.; Adamow, M.; Ginsberg, B.; Rasalan, T. S.; Ritter, E.; Gallardo, H. F.; Xu, Y.; Pogoriler, E.; Panageas, K. S.; more...
    Journal of Immunotherapy (2010)

    Fulltext@MSK | Save
  • Correlation of clinical and immunological data in a metastatic melanoma patient with heterogeneous tumor responses to ipilimumab therapy
    Journal Article

    Yuan, J.; Page, D. B.; Ku, G. Y.; Li, Y.; Mu, Z.; Ariyan, C.; Gallardo, H. F.; Roman, R. A.; Heine, A. I.; Terzulli, S. L.; more...
    Cancer Immunity (2010)

    Fulltext@MSK | Save
  • Cytotoxic T lymphocyte-associated antigen 4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with tumor regression
    Meeting Abstract

    Yuan, J.; Gnjatic, S.; Li, H.; Powel, S.; Gallardo, H.; Ritter, E.; Rasalan, T. S.; Manukian, G.; Xu, Y. Y. ; Terzulli, S.; more...
    Journal of Immunotherapy (2008)

    Fulltext@MSK | Save
  • Clinical results and immunologic correlates in metastatic melanoma patients treated with ipilimumab
    Meeting Abstract

    Wolchok, J. D.; Yuan, J.; Gnjatic, S.; Ritter, G.; Ritter, E.; Gallardo, H.; Powel, S.; Old, L. J.; Allison, J. P.
    Pigment Cell & Melanoma Research (2008)

    Fulltext@MSK | Save
  • Immune responses detected in urothelial carcinoma patients after vaccination with NY-ESO-1 protein plus BCG and GM-CSF
    Journal Article

    Sharma, P.; Bajorin, D. F.; Jungbluth, A. A.; Herr, H.; Old, L. J.; Gnjatic, S.
    Journal of Immunotherapy (2008)

    Fulltext@MSK | Save